A Double Blind, Prospective, Placebo Controlled, Randomised, Three Arm Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Collagen Peptide of Titan Biotech Limited in the Skin, Nail and Hair Health of Adult Subjects

Titan Biotech Limited0 个研究点目标入组 72 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Adults between 18 and 45 years of age (both ages and all sexes inclusive)
•2.Subjects with any skin type with a minimum of one concern
•ii.Dry, Dull Skin
•iii.Brittle Nails
•iv.Dry, Dull Hair
•v.Hair Fall, Breakage
•vi.Split Ends of the hair
•3.Subject/LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period and follow up period.
•4.Subjects who are willing not to participate in any other clinical trial during participation in the current trial.

•1.Subjects with known hypersensitivity to investigational product or its constituents.
•2.Subjects who have skin condition that prevent proper examination or evaluation of study criteria.
•3.Subjects who are on active treatments for skin and/or hair conditions.
•4.Subjects who have dyed their hair in the last 60 days.
•5.Subjects with immunucompromised state complications.
•6.Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.), any medical condition that is unstable/poorly controlled or other factor (e.g., planned relocation) that the Investigator felt would interfere with study evaluations and study participation.
•7.Females who are pregnant or lactating or planning to become pregnant during the study period.
•8.Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol.
•9.Subjects, who in the opinion of the Investigator or the Medical Experts are not eligible for enrolment in the study.

发起方

Titan Biotech Limited